If you would like to volunteer at any of our venues,
click here
Use PayPal to help support Alzheimer's victims.
Get our E-Mail updates!
July Alzheimer's News
Controversy Over Use Of Antipsychotic Drugs For Dementia, From The Harvard Mental Health Letter
July 27, 2007 - Antipsychotic drugs are approved mainly for treating schizophrenia and bipolar disorder, but they are also used for many other purposes. One of the most controversial is reducing disruptive behavior among elderly people with dementia. In the last few years, the FDA has required drug labels to carry warnings regarding this still-common practice, and studies continue to raise questions about its risks and benefits, reports the August 2007 issue of the Harvard Mental Health Letter. Read More...
Affiris Begins Clinical Testing Of Alzheimer's Vaccine
July 21, 2007 - The Alzheimer's vaccine known as Affitope AD01 from Affiris has now entered the clinical phase of its development. All relevant regulatory and statutory approvals have been secured and this innovative treatment is now being tested on humans for the first time. This development means that the 8.5 million-Euro venture capital finance agreement the company concluded with Munich-based MIG-Fonds in April 2006 has reached a key milestone on schedule. Read More...
Studies Advance Knowledge of Alzheimer's Disease July 21, 2007 - (Source: Therapeutics Daily) - Scientists in the United Kingdom report that mutations in the amyloid precursor protein (APP), tau and apolipoprotein E4 lead to Alzheimer's disease or related pathologies. Read More...
A new study suggests that the cholesterol-lowering drug Zocor may also help ward off Alzheimer's and Parkinson's. July 19, 2007 - Who wouldn't love to find a drug to help prevent or at least delay the onset of Alzheimer's disease? It turns out that one may already exist. Dr. Benjamin Wolozin, professor of pharmacology at Boston University School of Medicine, posted a study this week in the online journal BioMed Central Medicine showing that the cholesterol-lowering drug Zocor (simvastatin) reduced the incidence of both Alzheimer's disease and Parkinson's by about 50 percent in a population of 4.5 million veterans over a three-year period. By comparison, two other statin drugs—Lipitor (atorvastatin) and Mevacor (lovastatin)—showed little or no effect. Read More...
Analysis: Curry studied in Alzheimer's July 16 (UPI) -- The most active ingredient in Indian curry appears to help human immune cells remove substances implicated in Alzheimer's disease, researchers said Monday. Fiala and associates at UCLA began investigating curry because of epidemiological data that indicated that in populations in India where curry cuisine is common the incidence of Alzheimer's type dementia is low. Read More...
Frequent Brain Stimulation In Old Age Reduces Risk Of Alzheimer's Disease
July 7, 2007 - How often old people read a newspaper, play chess, or engage in other mentally stimulating activities is related to risk of developing Alzheimer's disease, according to a study published June 27, 2007, in the online edition of Neurology®, the medical journal of the American Academy of Neurology. Read More...
New Risk Factors Discovered For Alzheimer's Disease
July 6, 2007 - A recent study suggests that cognitively normal adults exhibiting atrophy of their temporal lobe or damage to blood vessels in the brain are more likely to develop Alzheimer's disease. Read More...
Controversy Over Use Of Antipsychotic Drugs For Dementia, From The Harvard Mental Health Letter
